Articles about Sanofi

Production of Sanofi-GlaxoSmithKline COVID-19 vaccine to begin within weeks

Production of another potential COVID-19 vaccine will begin within weeks, its developers Sanofi and GlaxoSmithKline said on Thursday as they launched a large trial enrolling 35,000 adult volunteers in the United States, Asia, Africa, and Latin America.

Sanofi-GSK vaccine candidate shows promising results

Sanofi and GlaxoSmithKline's potential COVID-19 vaccine triggered strong immune responses in all adults in preliminary trials, boosting optimism the shot may join the fight against COVID-19 this year.

Moderna's COVID-19 vaccine found to be 95% effective: Details here

American biotech company Moderna Therapeutics has announced that its COVID-19 vaccine was found to be nearly 95% effective in preventing the novel coronavirus disease.

UK planning "challenge trials" that deliberately expose volunteers to COVID-19

With the world waiting for a coronavirus vaccine with bated breath, the United Kingdom is looking to launch an unusual trial — one wherein volunteers would be intentionally infected with the virus to judge how effective a vaccine is.